Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions		3 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
Net Sales		$ 13,230	$ 10,703
Cost of sales		10,197	7,951
Research and development expenses		416	361
Selling, general and administrative expenses		867	742
Amortization of intangibles		155	103
Restructuring credits		(1)	(2)
Equity in earnings of nonconsolidated affiliates		196	39
Sundry income (expense) - net		(470)	(1,241)
Interest income		25	20
Interest expense and amortization of debt discount		219	201
Income Before Income Taxes		1,128	165
Provision (Credit) for income taxes		213	(110)
Net Income		915	275
Net income attributable to noncontrolling interests		27	21
Net Income Attributable to The Dow Chemical Company		888	254
Preferred stock dividends	[1]	0	85	[2]
Net Income Available for The Dow Chemical Company Common Stockholders		$ 888	$ 169
Per Common Share Data:
Earnings per common share - basic		$ 0.74	$ 0.15
Earnings per common share - diluted		0.72	0.15
Dividends declared per share of common stock		$ 0.46	$ 0.46
Weighted-average common shares outstanding - basic		1,202.5	1,102.9
Weighted-average common shares outstanding - diluted		1,222.1	1,117.3
Depreciation		$ 578	$ 456
Capital Expenditures		$ 754	$ 820

[1] On December 30, 2016, the Company converted its outstanding shares of Cumulative Convertible Perpetual Preferred Stock, Series A ("Preferred Stock") into shares of the Company's common stock.

[2] Preferred stock dividends were not added back in the calculation of diluted earnings per share for the three months ended March 31, 2016, because the effect of adding them back would have been antidilutive.